Candel Therapeutics (CADL) Debt Ratio (2020 - 2025)

Candel Therapeutics' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.01 for Q4 2025.

• In Q4 2025, Debt Ratio fell 92.01% year-over-year to 0.01; the TTM figure through Dec 2025 stood at 0.01 (down 92.01% YoY), while the FY2025 annual figure was 0.01, down 92.01% from the prior year.
• Debt Ratio came in at 0.01 for Q4 2025 at Candel Therapeutics, down from 0.05 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.61 in Q1 2024 to a low of 0.01 in Q1 2022.
• A 5-year average of 0.23 and a median of 0.24 in 2022 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio surged 5255.79% in 2023 and slumped 92.01% in 2025, its largest moves.
• Candel Therapeutics' Debt Ratio stood at 0.01 in 2021, then jumped by 4042.14% to 0.26 in 2022, then soared by 91.58% to 0.5 in 2023, then tumbled by 79.78% to 0.1 in 2024, then tumbled by 92.01% to 0.01 in 2025.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.01, 0.05, and 0.06 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison